Clinical Trial Update: Isoprinosine in HIV Patients With Viral Load > 50 y < 200 Copies/mL [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Isoprinosine in HIV-infected patients with viral load between 50 and 200 copies/mL; status not clearly specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Isoprinosine (inosine pranobex)

Snippet

Sponsor: Universidad San Francisco de Quito | Conditions: HIV Infections | Phase 4 | Status: UNKNOWN